Loading
institutionsInstitution
Chulabhorn Hospital / Chulabhorn Royal Academy
A royal-founded cancer hospital in Bangkok specialising in advanced diagnostics and nuclear medicine, home to Thailand's first cyclotron-based PET and radioligand therapy programme.
Also called: Chulabhorn Cancer CenterHRH Princess Chulabhorn College of Medical Scienceโรงพยาบาลจุฬาภรณ์
Overview
Chulabhorn Hospital opened in 2009 under the patronage of Princess Chulabhorn as a specialist cancer hospital attached to the Chulabhorn Research Institute, later becoming part of the Chulabhorn Royal Academy with its own college of medical science. It was established to bring advanced cancer diagnostics and treatment to Thai patients regardless of means, and is known for molecular imaging and nuclear medicine, including PSMA and DOTATATE PET and lutetium and actinium radioligand therapy, for a national cancer screening and early detection programme in underserved provinces, and for chemical carcinogenesis research at the Chulabhorn Research Institute. The academy operates a growing cancer centre and trains medical and allied health professionals.
Location
Bangkok, TH
Type
cancer center
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#222 · 26 points (0 Newsweek + 0 NCI + 26 from 13 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Chulabhorn Hospital, including child institutions. 61 works · 924 citations · 82% open access · 8% clinical trials · 0% reviews.
Oncology works per year
182022
162023
82024
92025
102026
Most works
- Juthamard Chantaraamporn7 works
- Chris Verathamjamras7 works
- Virat Luevisadpibul7 works
- Photsathorn Mutapat7 works
- Thiwaree Sornprachum7 works
- Somchai Chutipongtanate7 works
- Jisnuson Svasti7 works
- Chantragan Srisomsap7 works
- Voraratt Champattanachai7 works
- Daranee Chokchaichamnankit7 works
Most cited
- Nuclear medicine and theranostics
- Cancer screening outreach
- Chulabhorn Research Institute
- Medical education
Similar pages
- InstitutionPostgraduate Institute of Medical Education and Research, Chandigarh
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET, Radioligand therapy (beta emitters).
- PairingBeta radioligand → alpha radioligand
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Targeted alpha therapy, Radioligand therapy (beta emitters).
- IdeaRegional radiopharmacy hubs and harmonised transport rules for short-lived isotopes
Shares Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters).
- TreatmentLocametz (kit for Ga-68 gozetotide)
Shares Theranostics, Lutetium-177 vipivotide tetraxetan, PSMA PET, PET/CT.
- PersonKen Herrmann
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET, Radioligand therapy (beta emitters).
- InstitutionInselspital, Bern University Hospital / University Cancer Center Inselspital
Shares Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- InstitutionEuropean Association of Nuclear Medicine
Shares Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Targeted alpha therapy.
- InstitutionIRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)
Shares Theranostics, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET.
cancers
fronts
technologies
drugs
ApprovedRadioligand therapy (beta)
Lutetium-177 dotatate · Lutathera
ApprovedRadioligand therapy (beta)
Lutetium-177 vipivotide tetraxetan · Pluvicto